sample bottle was tightly sealed with a screw cap. The bottle was
then heated with shaking until all the solid material had dissolved.
The solution was set aside and allowed to cool to 25 ◦C. Gelation
was stable to inversion when the sample bottle was turned upside
down.
MS (FAB): 470 (M + H)+ (calcd MW = 469.1); elemental analysis
calcd (%) for C20H23NO12: C 51.18, H 4.94, N 2.98; found: C 51.01,
H 5.24, N 2.86.
(2R,3R,4S,5R,6S)-2-(Acetoxymethyl)-6-(4-aminophenoxy)-
tetrahydro-2H-pyran-3,4,5-triyl triacetate (9). Compound
8
(1.0 g) was dissolved with 25 mL of MeOH. After 5 min of N2
purging, Pd on activated carbon (10 wt%, 100 mg) was added.
Under 2 atm of H2, the reaction was allowed to proceed for 3 h.
After filtration and evaporation, pure 9 was obtained as a pale
yellow solid (2.48 g, quantitative). (1/1 v/v, Rf = 0.5). Yield 75%.
Synthesis
Compounds 3, 4, 6 and 7 are commercially available.
N -(4-((2S,3S,4S,5S )-3,4,5-Trihydroxy-6-(hydroxymethyl)-
tetrahydro-2H-pyran-2-yloxy)phenyl) heptadeca-10,12-diynamide
(1). A mixture of 9 (0.15 g, 0.33 mmol) and NaOH (0.52 g,
1.3 mmol) in MeOH (16 mL) and H2O (4 mL) was stirred for 3 h
at room temperature. The solution was concentrated in vacuo, and
acidified with 0.1 M HCl solution. The pr◦ecipitate was filtered and
dried in vacuo. White solid. Mp: 123–126 C. Yield 90%. 1H NMR
(300 MHz, DMSO-d6): d 9.70 (s, 1H, NH), 7.49 (d, 2H, J = 9,
Ar–H), 6.97 (d, 2H, J = 9, Ar–H), 5.24 (d, 1H), 5.24 (d, 1H), 5.02
(d, 1H), 4.96 (d, 1H), 4.77(d, 1H), 4.52(t, 1H), 3.72 (m, 1H), 3.48
(m, 1H), 3.26(s, 5H), 2.30 (m, 6H), 1.57 (m, 2H), 1.45–1.28 (m,
14H), 0.89 (t, 3H, CH3); 13C NMR (75 MHz, CDCl3): 181.3, 148.4,
125.1, 118.8, 115.3, 85.3, 74.5, 70.6, 65.8, 64.6, 63.1, 25–28, 20.5,
13.1 ppm; IR (KBr, cm−1): 3378, 3288, 2929, 2850, 1654, 1604,
1533, 1509, 1407, 1234, 1074; MS (FAB): 544 (M + H)+ (calcd
MW = 543.3); elemental analysis: calcd (%) for C31H45NO7: C
68.10, H 8.44, N 2.54; found: C 68.48, H 8.34, N 2.58.
◦
1H NMR (300 MHz, CDCl3, 25 C): d 6.85 (d, 2H, J = 9, Ar–
H), 6.64 (d, 2H, J = 9, Ar–H), 5.24 (m, 3H), 4.96 (d, 1H, J =
9), 4.3–4.1 (m, 2H), 3.81 (m, 1H), 3.48 (s, 2H), 2.05 (s, 12H); 13
C
NMR (75 MHz, CDCl3): 170.3, 158.9, 130.2, 121.0, 119.3, 97.1,
73.4, 69.1, 64.6, 20.5, 19.1 ppm; MS (FAB): 438 (M + H)+ (calcd
MW = 439.1); elemental analysis: calcd (%) for C20H25NO10: C
54.89, H 6.10, N 3.40; found: C 54.67, H 5.73, N 3.19.
(3R,4S,5S,6S)-2-(Acetoxymethyl)-6-(4-heptadeca-10,12-diyn-
amidophenoxy)-tetrahydro-2H-pyran-3,4,5-triyl triacetate (10).
A mixture of 5 (0.15 g, 0.34 mmol), 9 (0.1 g, 0.34 mmol), and
triethylamine (0.17 g, 1.7 mmol) in dry THF (20 mL) was refluxed
for 3 h under N2 atmosphere. The solution was filtered after cooling
to room temperature, and concentrated in vacuo. The residue was
purified by column chromatography on silica gel with EA/Hx (2/1
1
v/v, Rf = 0.6). Yield 75%. H NMR (300 MHz, CDCl3): d 9.70
(s, 1H, NH), 7.49 (d, 2H, J = 9, Ar–H), 6.97 (d, 2H, J = 9, Ar–
H), 5.21 (d, 1H), 5.16 (d, 1H), 4.98 (d, 1H), 4.91 (d, 1H), 4.75(d,
1H), 4.58(t, 1H), 3.78 (m, 1H), 3.35 (m, 1H), 3.21(s, 5H), 2.33
(m, 6H), 2.08 (m, 12H), 1.53 (m, 2H), 1.45–1.28 (m, 14H), 0.83
(s, 3H, CH3); 13C NMR (75 MHz, CDCl3): 180.2, 169.3, 155.4,
129.1, 119.9, 119.1, 89.1, 77.4, 71.3, 69.1, 64.6, 61.1, 25–28, 20.5,
19.1, 12.8 ppm; MS (FAB): 713 (M + H)+ (calcd MW = 711.4);
elemental analysis calcd (%) for C39H53NO11: C 65.14, H 8.21, N
2.01; found: C 65.80, H 7.50, N 1.97.
N -(4-((2S,3S,4S,5S )-3,4,5-Trihydroxy-6-(hydroxymethyl)-
tetrahydro-2H-pyran-2-yloxy)phenyl)heptadecanamide (2). Syn-
thetic procedures are same as for 1 starting from 11. H NMR
1
(300 MHz, DMSO-D6): d 9.60 (s, 1H, NH), 7.50 (d, 2H, J = 9,
Ar–H), 6.88 (d, 2H, J = 9, Ar–H), 5.13 (d, 1H), 5.20 (d, 1H),
4.99 (d, 1H), 4.88 (d, 1H), 4.70(d, 1H), 4.61(t, 1H), 3.80 (m, 1H),
3.18(s, 5H), 1.50 (m, 2H), 1.45–1.28 (m, 30H), 0.82 (m, 3H, CH3);
13C NMR (75 MHz, CDCl3): 171, 131.0, 121.5, 116.2, 102.2, 71.1,
66.0, 65.7, 65.2, 64.2, 31–27, 21.5, 12.5 ppm; IR (KBr, cm−1): 3375,
3288, 2929, 2850, 1654, 1600, 1535, 1512, 1407, 1234, 1072; MS
(FAB): 538.5 (M + H)+ (calcd MW = 537.73); elemental analysis:
calcd (%) for C30H51NO7; C 67.01, H 9.56, N 2.60. found: C 65.07,
H 9.11, N 2.50.
( 3R,4S,5S,6S ) - 2 - ( Acetoxymethyl ) - 6 - ( 4 - heptadecanamido
phenoxy)-tetrahydro-2H-pyran-3,4,5-triyl triacetate (11). The
same reaction procedures as for 10 were used starting from stearoyl
chloride and 9. 1H NMR (300 MHz, CDCl): d 9.70 (s, 1H, NH),
7.49 (d, 2H, J = 9, Ar–H), 6.97 (d, 2H, J = 9, Ar–H), 5.21 (d, 1H),
5.16 (d, 1H), 4.98 (d, 1H), 4.91 (d, 1H), 4.75(d, 1H), 4.58(t, 1H),
3.78 (m, 1H), 2.08 (m, 12H), 1.53 (m, 2H), 1.45–1.28 (m, 30H),
0.82 (m, 3H, CH3); 13C NMR (75 MHz, CDCl3): 178, 171.2, 156.2,
128.6, 121.4, 110.6, 97.1, 75.0, 73.1, 66.1, 65.1, 64.1, 33–27, 20.8,
16.1; MS (FAB): 706.5 (M + H)+ (calcd MW = 705.41); elemental
analysis: calcd (%) for C38H59NO11: C 64.66, H 8.42, N 1.98.; found:
C 64.35, H 8.22, N 2.00.
10, 12-Heptadecadiynoyl chloride (5). A mixture of 10,12-
heptadecadiynoic acid 3 (0.10 g, 0.37 mmol), 4 (0.12 mL,
3.96 mmol) and DMF (1 ∼ 2 drops) was dissolved in CH2Cl2
(2.0 mL), and the reaction mixture was then stirred for 10 h at
room temperature. The residual oxalyl chloride and solvent were
removed in vacuo. The product was directly used for the coupling
reaction without further purification.
(2R,3R,4S,5R,6S )-2-(Acetoxymethyl)-6-(4-nitrophenoxy)-
tetrahydro-2H-pyran-3,4,5-triyl triacetate (8). Nitrophenyl-b-D-
glucopyranoside 6 (1.0 g, 2.54 mmol) was dissolved in 1.0 mL of
pyridine and 1.0 mL of 7. The reaction mixture was allowed to
stand overnight and was then evaporated in vacuo to dryness with
dry toluene. The residue was purified by column chromatography
on silica gel with EA/Hx (1/1 v/v, Rf = 0.5). Yield 75%. 1H NMR
(300 MHz, CDCl3): d 7.23 (d, 2H, J = 9, Ar–H), 7.08 (d, 2H,
J = 9, Ar–H), 5.24 (m, 3H), 5.04 (d, 1H, J = 9), 4.3–4.1 (m, 2H),
3.87 (m, 1H), 1.97 (s, 12H); 13C NMR (75 MHz, CDCl3): 170.5,
158.6, 130.5, 123.1, 115.3, 98.1, 71.4, 68.3, 65.4, 20.8, 19.6 ppm;
Acknowledgements
This work was supported by the KOSEF (F01-2004-10061-0 and
R01-2005-000-10229-0).
References
1 For recent comprehensive reviews, see: (a) E. Otsuni, P. Kamaras and
R. G. Weiss, Angew. Chem., Int. Ed. Engl., 1996, 35, 1324; (b) P. Terech
and R. G. Weiss, Chem. Rev., 1997, 97, 3133; (c) J. H. van Esch and
This journal is
The Royal Society of Chemistry 2006
Org. Biomol. Chem., 2006, 4, 2033–2038 | 2037
©